Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed1
Recruiting2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT06133231Not ApplicableRecruiting
Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)
Attention Deficit/Hyperactivity DisorderEmotional DysfunctionIrritable Mood
PrincipalinvestigatorStart date: 2024-01-06
NCT05930886Recruiting
Focus Groups in Ethnically and Racially Diverse Families
Attention Deficit/Hyperactivity DisorderEmotional DysfunctionIrritable Mood
PrincipalinvestigatorStart date: 2023-04-15
NCT05234593Not ApplicableCompleted
Feasibility and Acceptability of Powdered Multinutrient Formula
Attention Deficit Hyperactivity Disorder
PrincipalinvestigatorStart date: 2022-08-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Oregon Health and Science University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Patrick J. McGrath, PhD.

IWK Health Centre

Related
6 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Daniel S Pine, M.D.

National Institute of Mental Health (NIMH)

Related
10 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Ru-Lan Hsieh, MD

Shin Kong Wu Ho-Su Memorial Hospital

Related
13 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Renana Eitan, MD

Hadassah Medical Organization

Related
5 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Sabine Wilhelm, PhD

Massachusetts General Hospital

Related
9 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Theresa Winhusen, Ph.D.

University of Cincinnati

Related
6 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Karen Sepucha, PhD

Massachusetts General Hospital

Related
10 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Roger deBeus, PhD

Skyland Behavioral Health Associates

Related
2 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Nobuhito Sanada

Otsuka Pharmaceutical Co., Ltd.

Related
11 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Susan Shur-Fen Gau, MD, PhD

Dept of Psychiatry, National Taiwan University Hospital

Related
6 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06133231Not ApplicablePrincipalInvestigator

Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)

Attention Deficit/Hyperactivity DisorderEmotional DysfunctionIrritable Mood
Recruiting
NCT05930886PrincipalInvestigator

Focus Groups in Ethnically and Racially Diverse Families

Attention Deficit/Hyperactivity DisorderEmotional DysfunctionIrritable Mood
Recruiting
NCT05234593Not ApplicablePrincipalInvestigator

Feasibility and Acceptability of Powdered Multinutrient Formula

Attention Deficit Hyperactivity Disorder
Completed

All 3 trials loaded